|
|
|
From the Directors
As an investigator, you often wonder if you are on the right track. For the CTSC, the answer to that question came in the form of the renewal of our original five year award.
It is with great pride and satisfaction that we announced the five year, $64.6 million renewal at a press conference at the Iris S. and Bert L. Wolstein Research Building at Case Western Reserve University on Friday, August 10th. It was also a pleasure to announce that it is the largest grant award ever in Northeast Ohio.
In an era when getting government funding for anything is a monumental task, it is truly a remarkable accomplishment for all of us at the CTSC to receive such resounding support from the NIH. All of us that have worked so hard in the first phase of the grant should feel very proud.
The conference was attended by over 200 people and kicked off with Case Western Reserve University President Barbara Snyder.
"I am so proud that we have achieved new levels of cooperation across our institutions and our research is better for it," Snyder said. "We are just beginning to tap what is possible with our collective expertise."
The event closed with senior United States Senator Sherrod Brown crystallizing the importance of our work to the state of Ohio and the country.
"There is no question that some of the best healthcare in the world takes place within a few miles of here."
We are grateful for the opportunity to continue our CTSC mission of bringing research from lab to life for another five years. It is an especial point of pride that our efforts have the full support of our partner institutions, the community, our investigators and staff, as well as the state, local and federal governments. We are indeed on the right track!
We hope that over the next 5 years, more and more investigators will engage more fully in all that the CTSC has to offer. Whether you are interested in our cores, funding opportunities, community-based research, and educational opportunities or seek guidance on study design, regulatory issues, or participant recruitment, the CTSC is there to provide assistance in expediting your research.
We invite you to view the video of the press conference.
Please enjoy the remainder of the summer!
Pamela B. Davis, M.D., PhD.
|
Three Major Ohio Universities Establish Statewide Research Collaboration
Streamlined Study Protocols Shave Lag Time and Accelerate Research Between Ohio's Major Biomedical Hubs
The three Clinical and Translational Science Award (CTSA) institutions in Ohio - Case Western Reserve University, University of Cincinnati and The Ohio State University - and their partnering institutions have established a statewide collaborative agreement allowing a single organization's Institutional Review Board (IRB) to assume IRB responsibilities on behalf of multiple institutions when conducting multicenter studies. This collaborative effort will serve to accelerate research by streamlining human subject protection processes when participating institutions are partnering on research projects requiring IRB approvals. This is the first reciprocity agreement among multiple CTSA organizations and encompasses eight legally separate institutions in Ohio. More
|
|
Dr. Sumitra Khatri and Dr. Lara Jehi take on CTSC Roles
The CTSC would like to welcome Dr. Sumitra Khatri and Dr. Lara Jehi, who are assuming the roles of Lara Danziger-Isakov.
Dr. Khatri is the Research Subject Advocate (RSA) at the Cleveland Clinic CRU. She is an adult pulmonary and critical care physician with a specialized focus in asthma. Her interests include severe asthma and environmental and oxidative stress in asthma. Dr. Khatri is "glad to be involved in the collaborative research environment across these institutions" and is excited to be involved with the latest research the CTSC has to offer.
Dr. Jehi is the CRU Associate Program Director at Cleveland Clinic. She is board-certified in neurology and clinical neurophysiology. Her clinical interests include, medical treatment of epilepsy, epilepsy surgery and treatment outcome analysis. She is also focused on research pertaining to appropriate selection of epilepsy surgery patients and defining predictors and mechanisms of seizure outcome following epilepsy surgery. Dr. Jehi said she is looking forward to her new role at the CRU and to new opportunities at expanding the Neurological and neurosurgical research utilization of the CRU.
|
|
Congratulations to the Recipients of the July 2012 CTSC Core Utilization Awards!
Monica Montano, Ph.D.
Case Western Reserve University School of Medicine
"Role of HEXIM1 in the protection against ischemic stress"
Priyadarshini Senanayake, Ph.D.
Cleveland Clinic
"Angiotensin(1-7) a specific therapeutic target for the treatment of retinal diabetic pathology"
View the list of 2012 Core Pilot recipients.
About the CTSC Core Utilization Pilot Program:
The CTSC of Case Western Reserve University Core Utilization Pilot Program supports investigator use of and familiarity with CTSC Core operations and personnel, in anticipation of applications for external funding using CTSC resources. Ideal uses may be to run tests on samples already collected; build cross-disciplinary collaborative programs; or develop enabling technologies, new therapeutic, diagnostic or outcomes and more.
The CTSC Core Utilization Pilot Grant has a rolling submission format. Applications are accepted year-round and submissions are reviewed monthly.
For more information contact the:
CTSC Research Concierge Service
|
|
|
|
 |
|
CTSC KL2 Informational Sessions
The CTSC KL2 program is holding informational meetings for those interested in the program. Upcoming sessions will be held at the following locations:
MetroHealth Medical Center
August 23, 2012
9 a.m. - 10 a.m
Rammelkamp R219
Case Western Reserve University
August 30, 2012
12 p.m. - 1:00 p.m.
Wolstein Research Bldg, Room 6136
Cleveland Clinic:
September 7, 2012
9:00 a.m. - 10:00 a.m.
NI Research & Development Office
JJ3 606 (South)
For questions/reservations, please contact Beth Spyke: spykeb@ccf.org
216-444-2702.
About the CTSC KL2
The CTSC KL2, a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, is accepting applications. Qualified candidates are being offered an opportunity to apply to an innovative career development program for clinical investigators. The CTSC KL2 is designed to train the nation's future leaders in clinical and translational research.
Qualified candidates
- Hold an M.D., Ph.D., D.D.S., Pharm.D., Psy.D. or an equivalent degree
- Have demonstrated a keen interest in clinical research
- Need an appointment in one of the Departments in the University or medical centers
- Are U.S. citizens or have permanent resident status
Applications are encouraged from physicians, nurses, dentists, social and behavioral scientists, engineers, biostatisticians, epidemiologists, bioethicists and other professionals with expertise relevant to clinical research.
Please visit our website for more information
For questions or assistance, please contact Beth Spyke, MPA at spykeb@ccf.org or 216-444-2702.
|
|
Ohio Health Data Symposium
Thursday August 30, 2012
10am -3pm
Wolstein Research Building
Free Registration
Lunch Provided
The Purpose of the symposium is to facilitate introductions between academic, research, clinical and governmental entities in Ohio, present current projects and ideas that utilize Ohio Health Data and foster communication, collaboration and resources across the state.
For questions or to register:
|
RDCRN's 3rd Conference on Clinical Research for Rare Diseases
Oct. 2, 2012 Rockville, MD
Registration for ALL attendees is $100
The conduct of clinical research in rare diseases is essential.
In order to assure the future of this research, the training of the next generation of investigators in this field is important.
Attendees have the opportunity to:
- Meet key leaders in rare diseases research
- Engage in networking and idea generation and explore research collaborations
- Discuss career development and strategic planning
Click HERE for more information
|
|
EMBL-EBI Roadshow: Now Open to Bionformatics Investigators From All CTSAs
October 16-18, 2012
Chicago, IL 60611
Registration Deadline:
September 28, 2012
Fee: $100
Seating limited to 30- register early!
*All attendees are required to bring their own wireless-enabled laptops.*
The October 2012 Roadshow at Northwestern University will focus on Small Molecules in Bioinformatics (ChEMBL, ChEBI), Protein Sequence Databases (UniProt), Interactions and Pathways (IntAct, Reactome), Standards and Ontologies (GO/GoA) and the European Nucleotide Archive (ENA).
Click HERE to view a flyer.
For more information contact:
|
|
